EpiVax Wins $600K SBIR Grant to Develop Vaccine Against H. Pylori | GenomeWeb

NEW YORK, May 5 (GenomeWeb News) - The US National Institutes of Health awarded EpiVax a $600,000 Phase I Small Business Innovation Research grant to develop a vaccine to Helicobacter pylorus, a common cause of peptic ulcers, the company said last week.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: variation patterns in wheat lines, regulatory variation in Capsella grandiflora, and more.

A Rockefeller University researcher is using edited ants to explore complex biological systems, the New York Times writes.

There's a heritable aspect to how much time people spend online, the Los Angeles Times reports.

Stat News reports that Joseph Gulfo is another contender for FDA commissioner.